Mobile App Support for Opioid Use Disorder
(MPS Trial)
Trial Summary
What is the purpose of this trial?
The COVID-19 pandemic puts individuals recovering from opioid use disorders (OUDs), an already vulnerable population, at increased risk of overdose due to decreased access to treatment, decreased social support, and increased psychosocial stress. This proposal will test the efficacy of a promising mobile app-based peer support program, compared to usual care, in increasing recovery capital, improving retention in treatment, and reducing psychosocial adverse effects, among a national sample of people in recovery from OUD. If effective, it would provide an accessible, personalized, and scalable approach to OUD recovery increasingly needed during the COVID-19 pandemic.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the idea that Mobile App Support for Opioid Use Disorder is an effective treatment?
The available research shows that mobile app support can be an effective treatment for Opioid Use Disorder. One study found that a mobile app called 'uMAT-R' helped improve knowledge about medication-assisted treatment, which is a common barrier to starting treatment. Another study highlighted that a digital therapeutic app used alongside medication like buprenorphine was safe and effective for people seeking treatment. Additionally, mobile peer-support apps can help people engage more with their recovery process and reduce the chance of relapse by providing a platform for interaction with others who are also recovering. These apps can be especially useful for those who have limited access to traditional treatment options.12345
What safety data exists for mobile app support in opioid use disorder treatment?
The research provided does not directly address safety data for mobile app support in opioid use disorder treatment. However, it mentions the potential of mobile health technologies to assist in managing opioid-related harm and the use of digital therapeutics as an adjunct to traditional treatments. The safety and efficacy of a digital therapeutic were evaluated in a clinical trial (NCT00929253), but specific safety data for mobile apps like Mobile Peer Support App or Peer Recovery Support App is not detailed in the provided abstracts.25678
Is the Mobile Phone App a promising treatment for Opioid Use Disorder?
Research Team
Megan Ranney, MD, MPH
Principal Investigator
Brown University
Eligibility Criteria
This trial is for English-speaking adults over 18 who identify as being in recovery from or treatment for opioid use disorder (OUD) and own a smartphone. It's not open to those without an Android or iOS phone, anyone previously enrolled, individuals unable to consent, or people currently incarcerated.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the mobile app-based peer support program as an adjunct to usual care
Follow-up
Participants are monitored for changes in recovery capital and psychosocial effects
Treatment Details
Interventions
- Mobile Phone App
Find a Clinic Near You
Who Is Running the Clinical Trial?
Brown University
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
National Institutes of Health (NIH)
Collaborator
Indiana University
Collaborator